Synergistic anti-tumor efficacy by combination therapy of a self-assembled nanogel vaccine with an immune checkpoint anti-PD-1 antibody - RSC Advances (RSC Publishing)
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma | Scientific Reports
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
Frontiers | Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer
Molecules | Free Full-Text | Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology | HTML
Cancer: anti-PD-1 / PD-L1 antibodies, new solutions for immunotherapy - Servier
Antibody Engineering | Review | InvivoGen
The PD-1 Era Is Officially Here - Medelis
Definition of immune checkpoint inhibitor - NCI Dictionary of Cancer Terms - NCI
Frontiers | PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD- L1 Axis - ScienceDirect
Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy | Journal for ImmunoTherapy of Cancer
PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors | Journal for ImmunoTherapy of Cancer | Full Text